Wild Wisdom product walkthrough: patient, provider, operator, executive

Before a consultation, education can help a patient describe their concern and prepare questions. It should not select a treatment for them. After the consultation, the explanation should reflect the treating clinician’s recommendation, including its reasoning and relevant limitations.

Wild Wisdom’s documented patient journey includes selected Decision Stories and the clinician’s own recommendation, shown in the provider chapter. Its purpose is to make the decision easier to understand, while leaving “more information,” “not now” and “not for me” as legitimate responses.

Confirm which educational material exists for the proposed treatment line and who has reviewed it. One demonstration does not establish coverage of every procedure. Assess whether patients understand the choices and feel able to decline; conversion is not the only measure of a useful decision process.

Measure educational exposure, understanding and treatment follow-through separately. Record which material was shown, whether it was completed, what the patient reported understanding, and what happened at later stages. A booking alone does not prove comprehension; a confident answer does not establish clinical suitability.

Wild Wisdom’s documented workflow includes a short understanding check and patient-reported confidence questions. These are patient responses, not an algorithmic suitability score. The public material does not establish that the questions are validated clinical instruments.

For a pilot, define who was eligible to see each module, account for missing responses and compare like observation windows. Keep changes in self-reported understanding separate from changes in booking and completed treatment. Report observed differences with their limitations rather than assuming the education caused the difference.

A before-and-after image shows selected moments. A structured treatment journey can add context: sessions, timing, recovery, variation, changes to the plan and reasons someone chose not to continue. The two formats can complement each other.

Wild Wisdom’s Outcome Confidence demonstration, above, shows illustrative journeys over time. The examples are synthetic. They are not patient results, a prediction of an individual outcome or proof that similar patients will respond similarly.

For a real example, an evaluator should be able to identify its source, permission for use, clinical review and why it is relevant. Those details should accompany the example, including uncertainty and variation. When appropriate evidence is unavailable, the clinic should explain that limitation rather than imply a personalised forecast.

A booked next appointment is not a completed treatment series. To evaluate continuation, specify the clinician-approved plan, the observation window and which next sessions were due during that window.

Keep completed, overdue, not yet due, patient-paused and clinically changed or stopped plans distinct. A patient who is not yet due should not be counted as a dropout. A clinical decision to stop should not be treated as a sales failure. If the patient has not explained a non-return, its reason remains unknown.

The Wild Wisdom demonstration shows follow-through from initial intent through treatment and continuation, as the continuation reading above. The states listed here are the measurement criteria a clinic should agree for evaluation, not a claim that every state is already automated in the product.

The current screens illustrate the workflow. Establishing whether it improves series completion requires a real cohort, recorded missingness and enough follow-up to observe the agreed next steps.